Detailed answers about ASHFORT PHARMACEUTICALS UK LTD, including incorporation, status, business activity, and accounts information.
When was ASHFORT PHARMACEUTICALS UK LTD founded?
ASHFORT PHARMACEUTICALS UK LTD was officially incorporated on 30 January 2025 and is registered under company number 16219522. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ASHFORT PHARMACEUTICALS UK LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ASHFORT PHARMACEUTICALS UK LTD?
ASHFORT PHARMACEUTICALS UK LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ASHFORT PHARMACEUTICALS UK LTD do?
ASHFORT PHARMACEUTICALS UK LTD operates in the following sectors: 21100 - Manufacture of basic pharmaceutical products, 21200 - Manufacture of pharmaceutical preparations, 46460 - Wholesale of pharmaceutical goods, 46900 - Non-specialised wholesale trade. These SIC codes provide insight into the company's business activities and industry focus.
What is ASHFORT PHARMACEUTICALS UK LTD's registered address?
The registered office address of ASHFORT PHARMACEUTICALS UK LTD is 2ND FLOOR COLLEGE HOUSE, 17 KING EDWARDS ROAD,, RUISLIP,, LONDON,, UNITED KINGDOM, HA4 7AE. This is the official address filed with Companies House for legal and statutory correspondence.
Is ASHFORT PHARMACEUTICALS UK LTD financially stable?
Financial accounts for ASHFORT PHARMACEUTICALS UK LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.